ibiden - IBIDY
IBIDY
Close Chg Chg %
71.15 3.34 4.69%
Closed Market
74.49
+3.34 (4.69%)
Volume: 350.00
Last Updated:
Dec 12, 2025, 12:15 PM EDT
Company Overview: ibiden - IBIDY
IBIDY Key Data
| Open $74.49 | Day Range 74.49 - 74.49 |
| 52 Week Range 23.26 - 91.57 | Market Cap $10.70B |
| Shares Outstanding 139.62M | Public Float N/A |
| Beta 1.63 | Rev. Per Employee N/A |
| P/E Ratio 48.02 | EPS $1.70 |
| Yield 24.66% | Dividend $0.11 |
| EX-DIVIDEND DATE Sep 30, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 55.43 |
IBIDY Performance
| 1 Week | 4.69% | ||
| 1 Month | -18.65% | ||
| 3 Months | 112.83% | ||
| 1 Year | N/A | ||
| 5 Years | N/A |
IBIDY Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Ibiden - IBIDY
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 3.57B | 3.08B | 2.56B | 2.42B | |
Sales Growth
| +17.04% | -13.69% | -16.84% | -5.42% | |
Cost of Goods Sold (COGS) incl D&A
| 2.50B | 2.14B | 1.85B | 1.69B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 469.93M | 405.96M | 319.10M | 356.31M | |
Depreciation
| - | - | - | - | - |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| +11.45% | -14.43% | -13.39% | -8.75% | |
Gross Income
| 1.07B | 940.96M | 708.64M | 731.94M | |
Gross Income Growth
| +32.63% | -11.94% | -24.69% | +3.29% | |
Gross Profit Margin
| +29.93% | +30.54% | +27.66% | +30.20% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 438.35M | 406.97M | 379.68M | 431.00M | |
Research & Development
| 140.01M | 145.24M | 139.89M | 180.07M | |
Other SG&A
| 298.34M | 261.74M | 239.78M | 250.93M | |
SGA Growth
| -0.69% | -7.16% | -6.71% | +13.52% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 19.21M | 8.26M | 30.77M | 127.04M | |
EBIT after Unusual Expense
| 611.02M | 525.73M | 298.19M | 173.91M | |
Non Operating Income/Expense
| (79.97M) | 7.56M | 35.67M | 172.16M | |
Non-Operating Interest Income
| 916.59K | 7.05M | 8.52M | 14.37M | |
Equity in Earnings of Affiliates
| - | 17.80K | 7.38K | 13.83K | |
Interest Expense
| 3.78M | 4.18M | 5.82M | 8.57M | |
Interest Expense Growth
| +55.47% | +10.63% | +39.01% | +47.30% | |
Gross Interest Expense
| 3.78M | 4.18M | 5.82M | 8.57M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 527.28M | 529.10M | 328.04M | 337.49M | |
Pretax Income Growth
| +73.86% | +0.34% | -38.00% | +2.88% | |
Pretax Margin
| +14.77% | +17.17% | +12.80% | +13.93% | |
Income Tax
| 157.40M | 142.33M | 108.47M | 114.14M | |
Income Tax - Current - Domestic
| 169.51M | 175.42M | 106.40M | 140.07M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| (12.09M) | (33.09M) | 2.07M | (25.93M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | 17.80K | 7.38K | 13.83K | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 369.87M | 386.76M | 219.56M | 223.35M | |
Minority Interest Expense
| 2.95M | 1.67M | 1.79M | 2.27M | |
Net Income
| 366.92M | 385.09M | 217.77M | 221.08M | |
Net Income Growth
| +51.43% | +4.95% | -43.45% | +1.52% | |
Net Margin Growth
| +10.28% | +12.50% | +8.50% | +9.12% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 366.92M | 385.09M | 217.77M | 221.08M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 366.92M | 385.09M | 217.77M | 221.08M | |
EPS (Basic)
| 2.6282 | 2.7578 | 1.559 | 1.5829 | |
EPS (Basic) Growth
| +51.54% | +4.93% | -43.47% | +1.53% | |
Basic Shares Outstanding
| 139.61M | 139.64M | 139.68M | 139.67M | |
EPS (Diluted)
| 2.6282 | 2.7578 | 1.5542 | 1.4837 | |
EPS (Diluted) Growth
| +51.54% | +4.93% | -43.64% | -4.54% | |
Diluted Shares Outstanding
| 139.61M | 139.64M | 140.04M | 147.46M | |
EBITDA
| 1.10B | 939.94M | 648.07M | 657.26M | |
EBITDA Growth
| +57.53% | -14.56% | -31.05% | +1.42% | |
EBITDA Margin
| +30.82% | +30.51% | +25.29% | +27.12% |
An error occurred while fetching the data.
SEC Filings for Ibiden - IBIDY
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
An error occurred while fetching the data.